The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Astellas And Potenza Partner to Create Immuno-Oncology Therapeutics

April 22, 2015 11:25 am | by PRNewswire | News | Comments

Astellas Pharma Inc. and Potenza Therapeutics, Inc., a biotechnology company developing a portfolio of immuno-oncology programs, today announced an exclusive research and development collaboration. 


Vical to Manufacture HIV Vaccines for Clinical Evaluation

April 22, 2015 11:22 am | by Globe Newswire | News | Comments

Vical Incorporated today announced that it has entered into a $4 million contract with the IPPOX Foundation to manufacture HIV-antigen plasmid DNA as a component of vaccine regimens to be evaluated in clinical trials for the prevention of HIV infection.


Roche Reports Strong Sales Growth in The First Quarter of 2015

April 22, 2015 11:17 am | by Roche | News | Comments

The Roche Group posted strong sales growth in the first three months in both divisions, with demand for oncology and immunology medicines driving growth in pharmaceuticals, and immunodiagnostics products driving growth in diagnostics.


Day One Wrap-up From INTERPHEX

April 22, 2015 11:04 am | by Advantage Business Media | Videos | Comments

What are the trends in thinking and tech advancements being highlighted at INTERPHEX? Advantage Business Media's Jeff Reinke talks with Russ Soma to get a day one wrap-up from the conference and find out what else is in store this week.


Marrone Bio Expands Research And Development Capacity

April 22, 2015 11:00 am | by Globe Newswire | News | Comments

Marrone Bio Innovations, Inc., a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the opening of its new greenhouse to facilitate and expand its research and product development capacity.


GW Pharmaceuticals Starts Second Phase 3 Trial For Epidiolex in Dravet Syndrome

April 22, 2015 10:50 am | by Globe Newswire | News | Comments

GW Pharmaceuticals announced today that it has initiated the second Phase 3 clinical trial of Epidiolex(R) (cannabidiol or CBD) for the treatment of Dravet syndrome, a rare and catastrophic treatment-resistant form of childhood epilepsy.


ESCMID Warns of Antibiotic Armageddon in UK And Europe by 2025

April 22, 2015 10:44 am | News | Comments

ESCMID warns that Europe may surpass one million deaths due to ineffective antibiotics by 2025.


ITT Showcases Valve And Pump Technologies at INTERPHEX

April 21, 2015 11:19 am | by ITT | News | Comments

ITT Corporation is showcasing its highly engineered valve technologies and solutions at Interphex, one of the world's largest trade shows for the biopharmaceutical industry.


SCHOTT to Demonstrate Vials at Interphex 2015

April 21, 2015 11:13 am | News | Comments

For the first time, the company will also be presenting a polymer prefillable syringe for sensitive drugs – the new SCHOTT TopPac SD.


Robotics And Medical Marijuana — A Joint Venture

April 21, 2015 11:03 am | by Meagan Parrish, Editor, Chem.Info | Articles | Comments

A startup company that’s found a unique niche in the exploding cannabis industry, Potbotics uses robotic technology to bring medical marijuana use into a new era of high-tech pharma.


Medical, Recreational Marijuana Stores Revenue to Grow 30.3 Percent Annually

April 21, 2015 10:58 am | by IBISWorld Media | News | Comments

The medical and recreational marijuana stores industry has reached new highs, riding a wave of legalization to become one of the fastest growing industries in the United States.


Eli Lilly Biomanufacturing Plant For Sale

April 21, 2015 10:54 am | News | Comments

CBRE Group, Inc. announced today that they have been hired to sell Eli Lilly’s biomanufacturing plant in Vacaville, California.


Inovio And Roche Initiate Trial For DNA Immunotherapy to Treat Hepatitis B

April 21, 2015 10:48 am | by Globe Newswire | News | Comments

Inovio Pharmaceuticals, Inc. announced today that it has initiated a phase I trial to evaluate Inovio's DNA immunotherapy in patients who are chronically infected with hepatitis B.


ELC Group Signs Regulatory Affairs Contract With Chinese Pharma Giant

April 21, 2015 10:43 am | by ELC Group | News | Comments

ELC Group, one of the fastest-growing providers of regulatory affairs services, today announces that it has been awarded a 1.5 million Euro contract by one of China’s biggest pharmaceutical companies.


Teva Offers to Buy Mylan in $40.1B Cash-And-Stock Deal

April 21, 2015 10:29 am | by The Associated Press | News | Comments

The potential combination would result in a powerhouse of a generic drug developer competing against rivals such as Sun Pharma.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.